Among active 13F managers last quarter, 9 opened and 11 added, while 13 reduced; the largest holder to move was NEA Management Company, LLC (−3.5%). Over the last 180 days, 1 insider bought and 1 insider sold, a net +$73K in open-market trades.
Funds lean in and no leg opposes.
88 tracked 13F filers disclose a position in CVRX as of the latest SEC 13F filings, a combined $84.5M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 4.0M | $20.7M | —Held | Q2 2026 | |
| 2 | NEA Management Company, LLC | 2.0M | $10.0M | ▼−3.5% Reduced · −72K sh | Q2 2026 | |
| 3 | BlackRock, Inc. | 1.2M | $6.4M | ▲+21% Added · +219K sh | Q2 2026 | |
| 4 | Vanguard Capital Management LLC | 911K | $4.7M | ▼−0.1% Reduced · −734 sh | Q2 2026 | |
| 5 | Royal Bank Of Canada | 707K | $6.7M | ▲67× Added · +696K sh | Q1 2026 | |
| 6 | Balyasny Asset Management L.P. | 631K | $6.0M | ▼−23% Reduced · −184K sh | Q1 2026 | |
| 7 | Silvercrest Asset Management Group LLC | 572K | $5.4M | ▼−9.9% Reduced · −63K sh | Q1 2026 | |
| 8 | Geode Capital Management, LLC | 441K | $2.3M | ▲+3.2% Added · +14K sh | Q2 2026 | |
| 9 | PFM Health Sciences, LP | 370K | $1.9M | ▲New +370K sh | Q2 2026 | |
| 10 | State Street Corp | 366K | $1.9M | ▲+4.5% Added · +16K sh | Q2 2026 | |
| 11 | Tudor Investment Corp Et Al | 206K | $1.1M | ▲+4.2% Added · +8K sh | Q2 2026 | |
| 12 | Goldman Sachs Group Inc | 201K | $1.9M | ▲+13% Added · +23K sh | Q1 2026 | |
| 13 | Northern Trust Corp | 150K | $1.4M | ▲+8.9% Added · +12K sh | Q1 2026 | |
| 14 | Morgan Stanley | 139K | $1.3M | ▼−63% Reduced · −241K sh | Q1 2026 | |
| 15 | Kestra Advisory Services, LLC | 132K | $681K | ▲+176% Added · +85K sh | Q2 2026 | |
| 16 | Vanguard Fiduciary Trust Co | 129K | $663K | ▲+0.9% Added · +1K sh | Q2 2026 | |
| 17 | Quantinno Capital Management LP | 116K | $1.1M | ▲+52% Added · +40K sh | Q1 2026 | |
| 18 | Two Sigma Investments, LP | 114K | $1.1M | ▲+367% Added · +90K sh | Q1 2026 | |
| 19 | Vanguard Portfolio Management LLC | 106K | $544K | ▲+12% Added · +11K sh | Q2 2026 | |
| 20 | Cresset Asset Management, LLC | 104K | $534K | ▼−2.4% Reduced · −3K sh | Q2 2026 | |
| 21 | UBS Group AG | 104K | $982K | ▲+17% Added · +15K sh | Q1 2026 | |
| 22 | BNP Paribas Financial Markets | 99K | $933K | ▲+58% Added · +36K sh | Q1 2026 | |
| 23 | AQR Capital Management LLC | 90K | $850K | ▲New +90K sh | Q1 2026 | |
| 24 | Citadel Advisors LLC | 79K | $406K | ▲+197% Added · +52K sh | Q2 2026 | |
| 25 | Dimensional Fund Advisors LP | 53K | $497K | ▼−1.0% Reduced · −542 sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 9 funds opened a new position in CVRX and 11 added to an existing one, while 13 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Eli Lilly & CoLLY | 39 funds | $33.0B |
| Nvidia CorpNVDA | 38 funds | $154.9B |
| Chevron CorpCVX | 38 funds | $9.7B |
| Apple IncAAPL | 37 funds | $108.5B |
| Microsoft CorpMSFT | 37 funds | $88.4B |
| Amazon.com IncAMZN | 37 funds | $70.1B |
| Broadcom IncAVGO | 37 funds | $65.4B |
| Alphabet Inc-CL AGOOGL | 37 funds | $65.0B |
| Meta Platforms Inc-Class AMETA | 37 funds | $43.6B |
| Advanced Micro DevicesAMD | 37 funds | $28.3B |
| Tesla IncTSLA | 37 funds | $26.9B |
| JPMorgan Chase & CoJPM | 37 funds | $22.9B |
Ranked by how many of CVRX's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in CVRX.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 13, 2026 | Binkowski Brent | CHIEF OPERATING OFFICER | Buy (P) | 26K | $76K |
| Aug 12, 2026 | Binkowski Brent | CHIEF OPERATING OFFICER | Sell (S) | 1K | $3K |
| Mar 2, 2026 | Hykes Kevin | PRES & CEO, Director | Sell (S) | 8K | $61K |
| Mar 2, 2026 | John Robert Allen | Chief Revenue Officer | Sell (S) | 4K | $31K |
| Mar 2, 2026 | Oasheim Jared | CHIEF FINANCIAL OFFICER | Sell (S) | 2K | $14K |
| Mar 2, 2026 | Verrastro Paul | CHIEF MKTG & STRAT OFFICER | Sell (S) | 1K | $10K |
| Mar 2, 2026 | Adamson Philip B. | Chief Medical Officer | Sell (S) | 1K | $10K |
| Feb 20, 2026 | Jain Mudit K. | Director | Buy (P) | 47K | $298K |
| Feb 18, 2026 | Jain Mudit K. | Director | Buy (P) | 600 | $3K |
| Nov 26, 2025 | Johnson &Amp; Johnson | 10% Owner | Sell (S) | 6K | $64K |
| Nov 26, 2025 | Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | Sell (S) | 6K | $64K |
| Nov 25, 2025 | Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | Sell (S) | 16K | $160K |
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 33 | 27 | – |
Insiders Form 4 open-market | 1 | 1 | +$73K |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for CVRX
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/CVRX/capital-change-brief"
Use Arkolith's capital_change_brief for CVRX. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for CVRX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.